Solitaire Pharmacia Private Limited

The combination of Glimepiride and Metformin is used to manage type 2 diabetes. Glimepiride stimulates insulin release from the pancreas, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they help control blood sugar levels effectively in diabetic patients when diet and exercise alone are insufficient.

The combination of metformin, glibenclamide, and pioglitazone is used to manage type 2 diabetes mellitus. It helps control blood sugar by improving insulin sensitivity (pioglitazone), increasing insulin secretion (glibenclamide), and reducing glucose production in the liver (metformin), offering a multi-mechanism approach to glycemic control.

The combination of glimepiride and pioglitazone is used to treat type 2 diabetes mellitus. Glimepiride stimulates the pancreas to release insulin, while pioglitazone improves the body’s sensitivity to insulin. Together, they help control blood sugar levels in patients who do not achieve adequate control with single-drug therapy.

Gliclazide is an oral antidiabetic medication used to manage type 2 diabetes mellitus. It belongs to the sulfonylurea class and works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels. It is often used when diet, exercise, and other medications do not provide adequate control.